ARK Genomic Revolution ETF vs Coinbase Global, Inc. — how do they compare? ARK Genomic Revolution ETF trades at $44.65, while Coinbase Global, Inc. trades at $148.43 (market cap $39.20B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Coinbase Global, Inc. nearer its low. Which is the better fit depends on your goals.
| ARKG | COIN | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $387.27 |
52-Week Low | $24.02 | $141.09 |
Market Cap | — | $39.20B |
Enterprise Value | — | $36.85B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
COIN trades at $148.4, down 0.19% with a bearish technical signal. Recent earnings misses and a net loss in Q2 2026 highlight challenges despite revenue growth. The stock faces pressure from a sluggish crypto market, but maintains strong cash flow and a 55% analyst buy rating with a $207.20 price target.
Outlook remains mixed: strong fundamentals like positive EBITDA and cash flow support long-term potential, but near-term risks from earnings volatility and market sentiment weigh on performance. Investors should balance growth prospects against sector headwinds.
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Coinbase Global, Inc. is a regulated cryptocurrency company that provides customers around the world with a platform for buying, selling, transferring, and storing digital assets. The Company offers a variety of products and services that enable individuals, businesses, and developers to participate in the cryptoeconomy.
Read more on COIN →